EMEA-001662-PIP01-14-M05
Table of contents
Key facts
| Active substance |
Palovarotene
|
| Therapeutic area |
Other
|
| Decision number |
P/0562/2021
|
| PIP number |
EMEA-001662-PIP01-14-M05
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of fibrodysplasia ossificans progressiva
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Ipsen Pharma
E-mail: abdelali.majdi@ipsen.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|